PAhR Therapeutics
pahrtx.com
Actively hiring
Cardiometabolic Therapeutics
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
RA Capital Management
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
RA Capital Management Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…
Refoxy Pharmaceuticals GmbH is a pre-clinical biotech company developing FOXO3-targeting therapies to restore cellular balance and treat…
Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated…
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…
Pulnovo Medical is pioneering Pulmonary Artery Denervation (PADN) for the treatment of pulmonary arterial hypertension and heart failure.
Terrestrial is transforming the delivery of next-generation therapies, starting with GLP-1. Terrestrial.
Overview
PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through novel biological mechanisms.